RSV Antibody Treatment Effective For Babies
TUESDAY, May 6, 2025-- Newborns can be effectively protected against respiratory syncytial virus (RSV) infection through the use of nirsevimab, a monoclonal antibody treatment, researchers report.Babies treated with nirsevimab had an 83% reduced...
Read more »